FDA Approved: RIMSO-50 — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a supplemental application for RimSO-50 (dimethyl sulfoxide) submitted by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• RimSO-50 (Dimethyl sulfoxide)

Snippet

SUPPL AP for RIMSO-50 (DIMETHYL SULFOXIDE)